In late 2025, SELLAS Life Sciences Group reported encouraging Phase 2 data for SLS009 in combination with azacitidine and venetoclax in relapsed or refractory acute myeloid leukemia and confirmed that ...

SELLAS Life Sciences Group (SLS) is back in focus after encouraging clinical updates on its leukemia programs, including Phase 2 data for SLS009 and ongoing progress in the Phase 3 REGAL trial for ...

SELLAS Life Sciences Group Inc. SLS has surged over 200% over the last six months, with a year-to-date stock jump of around ...

ICRA expects Sai Life Sciences to maintain strong growth momentum over the medium term on the back of a healthy growth outlook for the industry, good product mix and deepening customer engagement.

Over the past decade, Raise3D has established itself as a key player in professional polymer 3D printing. Initially known for ...

The debate centers on Sellas’ Phase 3 Regal trial, which is testing its immunotherapy Galinpepimut-S (GPS) as a maintenance ...

The CEO said Sellas is pursuing a “security force” immunotherapy strategy that trains immune cells to recognize cancer even as tumors evolve.

SpaceX and Blue Origin hold Human Lander System (HLS) flight service contracts with NASA to ferry astronauts to and from ...

NASA Administrator Jared Isaacman unveiled sweeping changes to the Artemis program, aimed at restoring momentum, reducing ...

NASA is streamlining its SLS rocket build and workflow to maintain skill sets, mitigate risk, and eventually launch every ...

The Senate Commerce Committee advanced a revised NASA authorization bill that implements some changes to Artemis sought by ...

NASA's Space Launch System rocket and Orion spacecraft for the Artemis II mission returned to the Vehicle Assembly Building ...